ClinConnect ClinConnect Logo
Search / Trial NCT04080466

Cam Type FAI is a Cause of Hip Pain in the Young Adult and a Precursor to OA

Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Sep 3, 2019

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Hip Cam Deformity

ClinConnect Summary

This clinical trial is studying a specific hip problem called a cam deformity, which is an abnormal shape of the hip joint that can cause pain and may lead to osteoarthritis (OA) if not treated. The goal is to understand how surgical treatment, which involves removing the cam deformity, can relieve pain and improve hip function in young adults who have been experiencing hip pain for more than six months. Researchers want to see how this surgery can help prevent further damage to the joint and reduce the chances of developing OA in the future.

To participate in the trial, individuals must be at least 18 years old and have hip pain for over six months, but they should not have any arthritis or significant joint deformities. Participants will undergo surgery and will need to attend follow-up visits to assess their recovery and improvements. It's important to note that certain conditions, such as recent joint injuries or specific health issues, may prevent someone from joining the study. This trial is currently recruiting participants, and anyone interested should discuss it with their healthcare provider to see if they qualify.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Skeletally mature patient undergoing cam resection by hip arthroscopy with hip pain longer than 6 months
  • Absence of arthritis (Tonnis Grade 0 or 1)
  • Absence of dysplasia (LCEA \> 25°) or overcoverage (LCEA \> 39°)
  • Alpha angle greater than 55° on multiplanar imaging
  • Subject is over the age of 18 years old at time of enrollment
  • Subject is willing and able to complete required study visits and assessments
  • Subject is willing to sign the approved Informed Consent Form
  • Group 2 Inclusion Criteria:
  • Normal femoral head neck contour and no evidence of dysplasia
  • Subject is over the age of 18 years old at time of enrollment
  • Subject is willing and able to complete required study visits and assessments
  • Subject is willing to sign the approved Informed Consent Form
  • Exclusion Criteria:
  • Prior joint replacement surgery in any lower-limb joint due to OA
  • History of lower-limb joint or back injury in the last year that impairs mobility
  • Metallic prosthesis
  • Worked with metal, metal fragments in the eye
  • Blood transmittable disease(s)
  • In vivo devices (Aneurysm clip(s), Pacemaker, ICD, Implanted hearing device)
  • Extreme claustrophobia
  • Overweight or obese (BMI \> 30) and/or waist circumference \>102cm in men and \>88cm in women
  • Diagnosis of Parkinson's or uncontrollable tremors
  • Known history of early OA in the immediate family
  • Pregnant, Breastfeeding, or planning to get pregnant
  • Cognitive impairment that prevents accurate completion of patient-reported outcome questionnaires
  • Patient unable/unwilling to complete all required follow-up visits
  • Participants who have been exposed to other sources of radiation within the last year (Bringing radiation exposure above annual maximum)

About Ottawa Hospital Research Institute

The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.

Locations

Ottawa, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Paul Beaule, MD, FRCSC

Principal Investigator

The Ottawa Hospital Research Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials